Update and new perspectives in the management of MDS
19 Dec 2011
Update and new perspectives in the management of MDS
New data on aggressive B cell lymphoma
Causes and drug development in ataxia telangiectasia
Update on the phase III VISTA trial
Romidepsin treatment in peripheral T cell lymphoma and subsets
Optimal treatment schedule for pomalidomide in multiple myeloma
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year
The changing landscape for NHL treatment
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer
Anaemia management update: blood transfusion and ESA use in oncology
Novel agents and proteasome inhibitors in myeloma
Advances in peripheral T-cell lymphoma